Management of tumour lysis syndrome in children: what is the evidence for prophylactic rasburicase in non-hyperleucocytic leukaemia?
Anurag K
AK
Agrawal
James H
JH
Feusner
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D005260:Female; D006074:Gout Suppressants / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D006801:Humans; D007223:Infant; D015470:Leukemia, Myeloid, Acute / Q000191:economics / Q000628:therapy*; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000191:economics / Q000628:therapy*; D015275:Tumor Lysis Syndrome / Q000191:economics / Q000209:etiology / Q000517:prevention & control*; D014503:Urate Oxidase / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics
D006074:Gout Suppressants; C469709:rasburicase; D014503:Urate Oxidase